HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Business (Wellness)

Set Alert for Business {Wellness}

Stada Looks To Take Slice Of Growing Probiotics Market With Launch Of Probielle In Germany

Stada Arzneimittel moves into the German probiotics market with four new products under its Probielle brand.
Wellness Dietary Supplements Launches

Horlicks Brings Unilever 'Transformative' Nutritional Deal, Market Challenges

Firm's Hindustan Unilever division will merge with s GSK Consumer Healthcare India which has had total sales around €550m so far in 2018, primarily through the Horlicks and Boost brands and with nearly 90% of the revenues in India. Also will acquire 82% stake in GSK Bangladesh and other GSK commercial operations and assets outside India, paying €3.3bn in combination of cash and shares in Hindustan Unilever.

Dietary Supplements Commercial M & A

FDA Review Of Dietary Ingredients For Pharmacy Compounding Could Open Door To Change DSHEA

FDA could look for Congress to amend DSHEA as it creates a “deep” administrative record on dietary ingredients placed on a list of substances no longer allowed for use by compounding pharmacies, says integrative medicine attorney Alan Dumoff. Pharmacy organizations are writing a citizen petition to ward off what they fear will be an excuse to step-up regulation of supplement manufacturing and marketing.

Regulation Dietary Supplements Advisory Committees

Deals

Set Alert for Deals {Wellness}

Latest From Wellness & Deals

ChromaDex Business Blooms After Pulling Niagen Claims Under NAD Review

Since Council of Better Business Bureaus investigators in May 2018 asked about claims for Tru Niagen, ChromaDex pulled the ads while reaching milestones in product distribution and ingredient licensing.
Dietary Supplements Ad Complaints

Canavation Adds Bio Lab Naturals, Launches CBme Skin Care Line

The acquisition "provides Canavation expanded vertical integration allowing us to focus on developing and distributing premium quality and highly differentiated consumer products," says CEO Bill Barlow.
M & A Dietary Supplements

Nestle's Atrium Adds LivingMatrix As New Cog In Personalized Health Strategy

Atrium expects to scale its nutrition personalization services by integrating LivingMatrix with its PureGenomics platform, which combines educational tools, protocols and core products with a practitioner website application to help identify and address single nucleotide polymorphisms.
Dietary Supplements M & A
See All

Strategy

Set Alert for Business Strategy {Wellness}

Latest From Wellness & Business Strategies

Health And Wellness Trademark Review 14 January, 2020

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Trademarks OTC Drugs

Claim That Supplement Boosts Children’s Focus Could Spur FTC Attention

Creekside Natural Therapeutics might hear from the FTC after failing to show in an industry self-regulation forum that it would correct misleading claims for its Focused Mind Jr. supplement promoted as an alternative to ADHD drugs.
Dietary Supplements Ad Complaints

CBD Safety And Hemp Farming Have Equal Space In Rep. Harris’ Concerns

“We ought to deal with this. There are questions on long-term safety and questions on efficacy claims that are just not proven,” says the Maryland Republican. “The biggest threat hanging over, in my mind, the farmers who want to grow hemp, is what if the FDA comes out tomorrow and says, ‘You can't sell any product’? The market collapses,”he said at a CBD policy conference.

Dietary Supplements FDA
See All

Sales & Earnings

Set Alert for Sales & Earnings {Wellness}

Latest From Wellness & Sales & Earnings

Wellness Market News: VSI, Mannatech Q3 Results, GoGenics, Hundred, Orgain Investments, One CBD Launch

One CBD launches as opioid alternative; EMEA drives Mannatech sales; VSI slumps in final quarter before sale; $3.2m financing for GoGenics; $8m technology investment in hundredInc.; and Butterfly buys Orgain majority stake.

Dietary Supplements Sales & Earnings

Perrigo's Combo For Growth: Bolt-on Acquisitions And New Products

CEO Murray Kessler says Perrigo's history shows "when it looks like we were winning, there was a certain level of bolt-on" acquisitions in addition to new products. The combination drove Perrigo in Q3 with reported worldwide consumer product net sales up 3.3% to $961m.
OTC Drugs Sales & Earnings

Bausch's Lumify Eye Drops Sales Jump To Double Competitors' Market Share

Lumify redness relief eye drops nearly doubled in sales between Bausch's second and third quarters and drove 7% organic growth of its global consumer business compared to the year-ago period. The brand has double the market share of its two closest competitors, and the firm plans clinical studies for product extensions to the brand in 2020.

OTC Drugs Dietary Supplements
See All

Litigation

Set Alert for Legal Issues

Latest From Wellness & Legal Issues

Federal Court Stays Class Action Against CBD Firm Green Roads To Await FDA Rulemaking

Plaintiffs against Florida-based Green Roads used certificates of analysis the company makes freely available to consumers to determine that batches of two of the company’s products contained “significantly” less cannabidiol versus labeled amounts. A Florida federal court rejected the firm’s motion to dismiss, but it is interested in seeing how FDA rulemaking develops.

United States Legal Issues

EU Wellness Market In 2019: The CBD Green Rush

INFOGRAPHIC: An interactive timeline of HBW Insight's coverage of the blossoming European CBD market in 2019. The timeline covers the main events of the year beginning with the European Commission's decision to classify CBD as a novel food, and ending on the filing of the first application for a synthetic form of the cannabis-derived ingredient.
Market Intelligence Europe

New York Supplement Firm Shut Down On GMP Violations Repeated Since 2010

ABH Nature’s and its owner, Mohammed Jahirul Islam, agree to a consent decree recently barring them from distributing adulterated and misbranded supplements and unapproved and misbranded drugs and requiring remedial action before restarting production. FDA records indicate its s inspections of the facilities began in 2010 and at least one GMP violation found in later inspections was noted in the first.
Dietary Supplements FDA
See All
UsernamePublicRestriction

Register